Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 58.75
-2.20 (-3.61%)
Sep 10, 2026, 11:44 AM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 56.25 billion as of September 9, 2026. Its market cap has increased by 450.99% in one year.
Market Cap
56.25B
Enterprise Value
55.84B
Revenue
1.96B
Ranking
n/a
PE Ratio
61.46
Stock Price
58.75
ChartMarket Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 56.25B, an increase of 445.37%. That is a compound annual growth rate of 52.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 56.25B | 138.50% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | 116.64B |
| Sino Biopharmaceutical | 104.10B |
| Akeso | 88.61B |
| Genscript Biotech | 75.84B |
| RemeGen | 66.99B |
| 3SBio | 40.95B |
| Shanghai Henlius Biotech | 35.82B |
| Shanghai Junshi Biosciences | 34.17B |